Chemical activators of TSPAN11 can orchestrate a cascade of biochemical events leading to its activation. Phorbol 12-myristate 13-acetate (PMA) is a potent activator of Protein Kinase C (PKC), which has a broad range of targets, including tetraspanins like TSPAN11. PKC can phosphorylate TSPAN11, thus modulating its activity and interactions within the cell membrane. Similarly, Forskolin acts upstream by elevating cyclic AMP (cAMP) levels, which activate Protein Kinase A (PKA). PKA then has the capability to phosphorylate TSPAN11, leading to its activation. This phosphorylation can alter TSPAN11's conformation or interaction with other cellular components, enhancing its function.
In parallel, Ionomycin and Thapsigargin both function by manipulating intracellular calcium levels. Ionomycin acts as a calcium ionophore, directly increasing intracellular calcium, which can activate calcium-dependent kinases. These kinases, in turn, are capable of phosphorylating TSPAN11. Thapsigargin disrupts calcium sequestration by inhibiting the sarcoplasmic/endoplasmic reticulum calcium ATPase (SERCA), resulting in elevated cytosolic calcium levels, which may lead to the activation of kinases that phosphorylate TSPAN11. Fingolimod, after being phosphorylated, yields sphingosine-1-phosphate, which can engage with its receptors to activate signaling pathways that culminate in the activation of TSPAN11. Hydrogen Peroxide, as a reactive oxygen species, can induce oxidative modifications of signaling molecules, which then activate kinases that target TSPAN11 for phosphorylation and activation. Anisomycin, which activates JNK signaling, also plays a role in stress response pathways that may include TSPAN11 phosphorylation and activation.
Moreover, the inhibition of protein phosphatases by compounds such as Calyculin A and Okadaic Acid results in sustained phosphorylation of cellular proteins. This inhibition prevents dephosphorylation, thus maintaining proteins like TSPAN11 in an activated state. Brefeldin A disrupts the structure and function of the Golgi apparatus, which initiates signaling pathways that can lead to TSPAN11 activation. A23187, by increasing calcium influx, can activate calcium-dependent kinases, which then target TSPAN11 for activation. Lastly, Bisindolylmaleimide I, despite being a PKC inhibitor, can paradoxically activate alternative pathways that result in the phosphorylation and subsequent activation of TSPAN11.
Items 41 to 12 of 12 total
画面:
製品名 | CAS # | カタログ # | 数量 | 価格 | 引用文献 | レーティング |
---|